SPL

1.05%

9.6¢ starpharma holdings limited

Wasn't the milestone going to be in Jan feb ??? Will you quit if...

First 3 Last

Share
Profile

Follow
mukesh2001

752 Posts.

23/03/17

22:40

Post #: 23587917
Share

Originally posted by biotechcatalyst ↑

gentlemen, there seems to a LOT of confusion around this trial. let me try to clear something up, i apologise in advance if i appear rude or condescending.

1) SPL is under no obligation to announce 'the trial is now complete'. They did not announce trial completion for last Phase 3 AND MOST companies do not announce this! SPL can announce it if they want but it adds nothing.

2) They have announced full recruitment. Thats all you need! THE TOPLINE DATA which will be announced in Q2 only needs to be the PRIMARY ENDPOINT. The rest of the data, including the follow up and other secondary endpoints can be announced later and sometimes the full data isnt released until the publication of the trial in a journal which can be up to a year! THIS IS NORMAL. calm down

3) Joel you had some question bout them moving the trial and adding 2 years or something? Mate seriously? The trial is FULLY RECRUITED, it cant be moved, no more patients are needed.

4) STOP WORRYING ABOUT TRIAL COMPLETION. All that matters is when we get top-line data. SPL have said we will get topline data early to mid Q2. Theres no reason why they cant follow through with that. There are no more variables that can add months or years to this trials, its locked down!

FINALLY, remember that this trial IS NOT being conducted by SPL. Its been conducted by Quintiles FOR SPL. Quintiles is the CRO. They are good at what they do. They will generate the topline and give to SPL to announced within the time frame. Stop doing this maths trying work something out that doesnt need to worked out using logic that i dont understand.

So in conclusion. Who gives a flying fruit when the trial is 'completed'. We are getting topline in early to mid Q2. THE END.

Expand

Wasn't the milestone going to be in Jan feb ??? Will you quit if nothing comes by end q2 ??? Dare.

SPL Price at posting: 66.0¢ Sentiment: Sell Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

OPL

Opyl forms JV with UK and US consortium to bring products to the world

PEC

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

Acquisitions roundup: European Lithium, Diatreme Resources and SRJ Technologies

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

HXL

Hexima shares rise 66% on proposed acquisition of AI player Real Thing Entertainment

Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%

AAI

NYSE-listed Alcoa Corp joins ASX through key JV acquisition

First 3 Last

Add SPL (ASX) to my watchlist

(20min delay)
Last 9.6¢		Change 0.001(1.05%)		Mkt cap ! $39.58M

Open	High	Low	Value	Volume
9.6¢	9.6¢	9.5¢	$11.41K	118.9K

Buyers (Bids)

No.	Vol.	Price($)
1	239840	9.5¢

Sellers (Offers)

Price($)	Vol.	No.
9.8¢	65000	1

View Market Depth

No.	Vol.	Price($)
1	239840	0.095
2	55000	0.094
2	239380	0.093
1	43260	0.092
4	24153	0.090

Price($)	Vol.	No.
0.098	65000	1
0.100	119205	4
0.105	66531	4
0.110	39609	6
0.115	138531	6

Last trade - 16.10pm 26/07/2024 (20 minute delay)

SPL (ASX) Chart

Wasn't the milestone going to be in Jan feb ??? Will you quit if...

Opyl forms JV with UK and US consortium to bring products to the world

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

Acquisitions roundup: European Lithium, Diatreme Resources and SRJ Technologies

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

Geochemical work at Newington picks up gold and copper anomalies for Midas

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Hexima shares rise 66% on proposed acquisition of AI player Real Thing Entertainment

Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%

NYSE-listed Alcoa Corp joins ASX through key JV acquisition

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Wasn't the milestone going to be in Jan feb ??? Will you quit if...

Top Stories

Opyl forms JV with UK and US consortium to bring products to the world

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

Acquisitions roundup: European Lithium, Diatreme Resources and SRJ Technologies

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

Geochemical work at Newington picks up gold and copper anomalies for Midas

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Hexima shares rise 66% on proposed acquisition of AI player Real Thing Entertainment

Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%

NYSE-listed Alcoa Corp joins ASX through key JV acquisition

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News